Clinical updates, including trial initiations, enrollment status and data readouts and publications: Anaptysbio, Avadel, Axsome, BMS, Eli Lilly, Enlivex, Genentech, Humanigen, Innovent, Kamada, Krystal, Logicbio, Ovid, Pharming, Precigen, Rhovac, Seres.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Caption Health.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Altimmune, Cstone, Everest, Ligand, Oncolys, Oncopeptides, Roche, Satsuma.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Beckman Coulter, Boston Scientific, Carmat, Veracyte.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Bioaegis, Boehringer, Dicerna, Idorsia, Levo, Medicinova, Nordic, Novartis, Personalized Stem Cells, Precigen, Rafael, Tessa.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Veracyte.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Algernon, Axcella, Biontech, Clovis, Cytodyn, Elios, Emmaus, Fosun, Hepion, KBP, Modag, Novavax, Palatin, Pfizer.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: AI, Ampio, Ascentage, Cerecor, Clarity, Cytodyn, Hutchison China Meditech, Immunic, Moderna, Opthea.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Avelas, Menarini.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Angion, Arch, Avelas, Cellectar, Clene, Karuna, Keros, GT, Novartis, Oncopeptides, Regenxbio.